UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009108
Receipt No. R000010681
Scientific Title A phase II neoadjuvant trial of concurrent trastuzumab, paclitaxel and endocrine therapy in women with HER2-positive and hormone receptor-positive breast cancer.
Date of disclosure of the study information 2012/10/17
Last modified on 2017/04/18 07:26:50

No. Disposal Last modified on Item of update
1 Insert 2012/10/13 16:45:57
2 Update 2012/10/15 21:15:31 Interventions/Control_1
Key exclusion criteria
3 Update 2012/10/15 21:17:46 Key inclusion criteria
4 Update 2013/10/14 16:37:27 TEL
Email
Last name of contact person
Last name of contact person
TEL
Email
5 Update 2015/10/21 09:20:15 Last name of lead principal investigator
Last name of lead principal investigator
Email
Last name of contact person
Last name of contact person
Email
Name of person sending information
Name of person sending information
Email
6 Update 2017/04/18 07:26:50 Name of primary sponsor
Organization


Contact us.